Jesse E. Otero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jesse E. Otero has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Thomas K. Fehring
OrthoCarolina Hip & Knee Center, Charlotte, North Carolina
6 shared publications - Keith A. Fehring
OrthoCarolina Hip & Knee Center, Charlotte, North Carolina
5 shared publications Thomas K. Fehring
OrthoCarolina Hip and Knee Center, Charlotte, North Carolina; Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
5 shared publications- Timothy Scott Brown
Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, Texas
4 shared publications - Aaron Joseph Tande
Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic , Rochester, Minnesota
3 shared publications - Angela L. Hewlett
Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska 68198
3 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Springer Nature in Biological Procedures Online
- Vol. 28  (1)
Development and Comparison of Two Rabbit Tibiofemoral Joint Replacement Models
Joint arthroplasty, replacement of damaged articular surfaces with a prosthetic component, is an increasingly common orthopaedic procedure. Despite the ove
- 3 July 2026
- Published by Springer Nature in Biological Procedures Online
- Vol. 28  (1)
Open AccessDevelopment and Comparison of Two Rabbit Tibiofemoral Joint Replacement Models
Joint arthroplasty, replacement of damaged articular surfaces with a prosthetic component, is an increasingly common orthopaedic procedure. Despite the ove
- 1 July 2026
- Published by SAGE Publications in HIP International
- Vol. 36  (6) , 997-1003
The true fate of the 2-stage revision arthroplasty for hip and knee prosthetic joint infection
Background: 2-stage revision arthroplasty remains the current gold standard for treatment of chronic periprosthetic joint infection (PJI) of the hip and knee in the United States. Rates of infection eradication have been shown to vary from 60% to 91%. The purpose of this study was to determine the true fate the of 2-stage exchange protocol for PJI using an updated classification system for PJI treatment outcomes as well as the effect of systemic host and local extremity grades on outcomes. Methods: A retrospective review of a PJI registry was performed from a single institution from January 2010 through December 2021. All patients having undergone a planned 2-stage exchange after primary or revision total knee arthroplasty (TKA) and total hip arthroplasty (THA) for chronic PJI defined by Musculoskeletal Infection Society criteria were included. Perioperative variables and tiered outcome at final follow up were collected. Results: In total, 589 cases (561 patients) met final inclusion criteria and were included in the analysis. 394 cases (66.9%) retained their implants at median follow-up of 3.7 years (IQR 1.8, 7.7). 311 cases (52.8%) underwent successful two-stage revision with prosthesis retention without ongoing use of suppressive antibiotics, while another 83 cases (14.1%) retained their prosthesis with use of suppressive antibiotics. 152 cases (25.8%) underwent subsequent septic or aseptic revision, amputation, arthrodesis, spacer retention while 40 (6.8%) died during the study period. Conclusions: At 3.7 years after surgery, 66.9% of 2-stage exchanges for PJI resulted in retained prosthesis with or without use of suppressive antibiotics. The remaining 33.1% of this population underwent additional surgery (25.8%), or were deceased (6.8%).
- 1 July 2026
- Published by SAGE Publications in HIP International
- Vol. 36  (6) , 997-1003
The true fate of the 2-stage revision arthroplasty for hip and knee prosthetic joint infection
Background: 2-stage revision arthroplasty remains the current gold standard for treatment of chronic periprosthetic joint infection (PJI) of the hip and knee in the United States. Rates of infection eradication have been shown to vary from 60% to 91%. The purpose of this study was to determine the true fate the of 2-stage exchange protocol for PJI using an updated classification system for PJI treatment outcomes as well as the effect of systemic host and local extremity grades on outcomes. Methods: A retrospective review of a PJI registry was performed from a single institution from January 2010 through December 2021. All patients having undergone a planned 2-stage exchange after primary or revision total knee arthroplasty (TKA) and total hip arthroplasty (THA) for chronic PJI defined by Musculoskeletal Infection Society criteria were included. Perioperative variables and tiered outcome at final follow up were collected. Results: In total, 589 cases (561 patients) met final inclusion criteria and were included in the analysis. 394 cases (66.9%) retained their implants at median follow-up of 3.7 years (IQR 1.8, 7.7). 311 cases (52.8%) underwent successful two-stage revision with prosthesis retention without ongoing use of suppressive antibiotics, while another 83 cases (14.1%) retained their prosthesis with use of suppressive antibiotics. 152 cases (25.8%) underwent subsequent septic or aseptic revision, amputation, arthrodesis, spacer retention while 40 (6.8%) died during the study period. Conclusions: At 3.7 years after surgery, 66.9% of 2-stage exchanges for PJI resulted in retained prosthesis with or without use of suppressive antibiotics. The remaining 33.1% of this population underwent additional surgery (25.8%), or were deceased (6.8%).
- Top Cited PapersOpen Access
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108  (14) , 1070-1082
One-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection
Background: A 2-stage approach is most commonly used to treat periprosthetic joint infection (PJI). Some successful studies of the 1-stage approach were underpowered, lacked a 2-stage comparative group, and excluded patients with draining sinuses, comorbidities, and/or antibiotic-resistant organisms. Given the morbidity and expense associated with 2-stage treatment, we conducted a prospective, multicenter, randomized trial to compare the results of 1- and 2-stage PJI treatment, specifically including patients with draining sinuses, comorbidities, and resistant organisms. Methods: Patients presenting for surgical treatment of a chronic PJI with a known organism following primary total hip or knee arthroplasty were included (with infection defined by Musculoskeletal Infection Society [MSIS] criteria). Patients with prior revision, culture-negative infection, or fungal infection, or who were immunosuppressed or had soft-tissue involvement precluding wound closure, were excluded. Patients were classified according to the McPherson host staging system. Clinical success was defined as (1) no clinical failure or reinfection with the same or new organism; (2) no reoperation for PJI; and (3) no PJI-related death. A double-instrument setup was used for all patients, as were similar irrigation and antibiotic protocols. A total of 323 patients (166 one-stage; 157 two-stage) were randomized. Groups were similar with respect to demographics and host classification. After excluding patients who died or were lost to follow-up, 258 of the 323 patients had 2-year follow-up (135 one-stage and 123 two-stage). The rate of patient loss to follow-up was similar between the treatment groups. Results: Sixteen patients in the 1-stage group and 9 patients in the 2-stage group died prior to 2-year follow-up. Overall, the 2-year success rate of 1-stage treatment was 97% (131 of 135), while the success of 2-stage treatment was 91% (112 of 123) (p = 0.04). Compared with the 2-stage group, the 1-stage group had 3-times the odds of overall success in a regression analysis (unadjusted odds ratio = 3.22 [95% confidence interval = 1.0 to 10.38]). After adjusting for specific variables (McPherson host grade, resistant organism, and draining sinuses), 1-stage treatment also had 3-times the odds of success. Conclusions: The results of this prospective randomized trial indicated that 1-stage treatment (97% success) was statistically noninferior to 2-stage treatment (91% success) when treating chronic PJI following primary total hip or knee arthroplasty, provided the protocols described here are explicitly followed. Extrapolation to other patient cohorts and clinical situations should be avoided. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108  (14) , 1070-1082
Top Cited PapersOpen AccessOne-Stage Versus Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection
Background: A 2-stage approach is most commonly used to treat periprosthetic joint infection (PJI). Some successful studies of the 1-stage approach were underpowered, lacked a 2-stage comparative group, and excluded patients with draining sinuses, comorbidities, and/or antibiotic-resistant organisms. Given the morbidity and expense associated with 2-stage treatment, we conducted a prospective, multicenter, randomized trial to compare the results of 1- and 2-stage PJI treatment, specifically including patients with draining sinuses, comorbidities, and resistant organisms. Methods: Patients presenting for surgical treatment of a chronic PJI with a known organism following primary total hip or knee arthroplasty were included (with infection defined by Musculoskeletal Infection Society [MSIS] criteria). Patients with prior revision, culture-negative infection, or fungal infection, or who were immunosuppressed or had soft-tissue involvement precluding wound closure, were excluded. Patients were classified according to the McPherson host staging system. Clinical success was defined as (1) no clinical failure or reinfection with the same or new organism; (2) no reoperation for PJI; and (3) no PJI-related death. A double-instrument setup was used for all patients, as were similar irrigation and antibiotic protocols. A total of 323 patients (166 one-stage; 157 two-stage) were randomized. Groups were similar with respect to demographics and host classification. After excluding patients who died or were lost to follow-up, 258 of the 323 patients had 2-year follow-up (135 one-stage and 123 two-stage). The rate of patient loss to follow-up was similar between the treatment groups. Results: Sixteen patients in the 1-stage group and 9 patients in the 2-stage group died prior to 2-year follow-up. Overall, the 2-year success rate of 1-stage treatment was 97% (131 of 135), while the success of 2-stage treatment was 91% (112 of 123) (p = 0.04). Compared with the 2-stage group, the 1-stage group had 3-times the odds of overall success in a regression analysis (unadjusted odds ratio = 3.22 [95% confidence interval = 1.0 to 10.38]). After adjusting for specific variables (McPherson host grade, resistant organism, and draining sinuses), 1-stage treatment also had 3-times the odds of success. Conclusions: The results of this prospective randomized trial indicated that 1-stage treatment (97% success) was statistically noninferior to 2-stage treatment (91% success) when treating chronic PJI following primary total hip or knee arthroplasty, provided the protocols described here are explicitly followed. Extrapolation to other patient cohorts and clinical situations should be avoided. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
- 6 November 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41  (7) , 2146-2153
Trends in Antibiotic-Resistant Bacteria in Surgically Treated Periprosthetic Joint Infection: A Decade of Experience at a Regional Referral Center
- 6 November 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41  (7) , 2146-2153
Trends in Antibiotic-Resistant Bacteria in Surgically Treated Periprosthetic Joint Infection: A Decade of Experience at a Regional Referral Center
- 17 July 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41  (1) , 47-53
Outcome of Debridement, Antibiotics, and Implant Retention for Treatment of Late Acute Hematogenous Periprosthetic Joint Infections
- 17 July 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41  (1) , 47-53
Outcome of Debridement, Antibiotics, and Implant Retention for Treatment of Late Acute Hematogenous Periprosthetic Joint Infections
- 18 June 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41  (2) , 589-594.e4
Timing of Failure of Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip and Knee
- 18 June 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41  (2) , 589-594.e4
Timing of Failure of Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip and Knee
- 28 February 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40  (8) , 1961-1966
Reinfection Patterns Following Two-Stage Exchange for Periprosthetic Joint Infection: A Retrospective Analysis
- 28 February 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40  (8) , 1961-1966
Reinfection Patterns Following Two-Stage Exchange for Periprosthetic Joint Infection: A Retrospective Analysis
- 23 May 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106  (14) , 1249-1255
What’s New in Musculoskeletal Infection
- 23 May 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106  (14) , 1249-1255
What’s New in Musculoskeletal Infection
- Open Access
- 23 April 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 27, 101351
Pasteurella multocida From a Cat Scratch as a Cause of Recurrent Prosthetic Joint Infection After Previously Successful Single-Stage Exchange Arthroplasty
- 23 April 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 27, 101351
Open AccessPasteurella multocida From a Cat Scratch as a Cause of Recurrent Prosthetic Joint Infection After Previously Successful Single-Stage Exchange Arthroplasty
- Open Access
- 22 January 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 25, 101271
Radiographic Cone Zone Classification of Metaphyseal Cone Fixation in Revision Total Knee Arthroplasty
- 22 January 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 25, 101271
Open AccessRadiographic Cone Zone Classification of Metaphyseal Cone Fixation in Revision Total Knee Arthroplasty